BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07646821-completion@plaintrial.com
DTSTAMP:20260928T050830Z
DTSTART;VALUE=DATE:20301211
SUMMARY:A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine 
 in Newly Diagnosed MDS/AML (≥ 10% Blasts) With TP53 Mutations — estima
 ted completion date
DESCRIPTION:Not yet recruiting. Saved on your PlainTrial shortlist. Full tr
 ial record: https://plaintrial.com/trial/NCT07646821
URL:https://plaintrial.com/trial/NCT07646821
END:VEVENT
END:VCALENDAR